WO2008093358A3 - Aqueous topical solution containing olopatadine - Google Patents
Aqueous topical solution containing olopatadine Download PDFInfo
- Publication number
- WO2008093358A3 WO2008093358A3 PCT/IN2008/000054 IN2008000054W WO2008093358A3 WO 2008093358 A3 WO2008093358 A3 WO 2008093358A3 IN 2008000054 W IN2008000054 W IN 2008000054W WO 2008093358 A3 WO2008093358 A3 WO 2008093358A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- topical solution
- aqueous topical
- solution containing
- olopatadine
- containing olopatadine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Otolaryngology (AREA)
- Ophthalmology & Optometry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to an aqueous topical solution comprising a therapeutically active ingredient consisting essentially of olopatadine or its pharmaceutically acceptable salt and a solubilizer selected from a group consisting of tyloxapol, vitamin E tocopheryl polyethylene glycol diesters of dicarboxylic acids and mixtures thereof, wherein the aqueous topical solution is stable.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN159/MUM/2007 | 2007-01-29 | ||
IN159MU2007 | 2007-01-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008093358A2 WO2008093358A2 (en) | 2008-08-07 |
WO2008093358A3 true WO2008093358A3 (en) | 2008-10-16 |
Family
ID=39674597
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2008/000054 WO2008093358A2 (en) | 2007-01-29 | 2008-01-29 | Aqueous topical solution containing olopatadine |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008093358A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2189157A4 (en) * | 2007-09-06 | 2012-10-31 | Kyowa Hakko Kirin Co Ltd | EYE DROP COMPRISING DIBENZO[b,e]OXEPIN DERIVATIVE |
CN102548536A (en) * | 2009-10-01 | 2012-07-04 | 爱尔康研究有限公司 | Olopatadine compositions and uses thereof |
CN109254102B (en) * | 2017-07-14 | 2022-02-15 | 上海联陆实业股份有限公司 | High performance liquid detection method for water-soluble vitamin E derivatives |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030055102A1 (en) * | 2001-06-27 | 2003-03-20 | Alcon, Inc. | Olopatadine formulations for topical administration |
US6743439B1 (en) * | 2001-06-27 | 2004-06-01 | Alcon, Inc. | Ophthalmic compositions containing copolymers of sulfonated styrene and maleic anhydride |
WO2005020962A1 (en) * | 2003-08-29 | 2005-03-10 | Novagali Pharma Sa | Self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs |
US20050209312A1 (en) * | 2004-03-19 | 2005-09-22 | Bausch & Lomb Incorporated | Carboxylic acid derivatives of doxepin formulations preserved with low-irritation preservative |
WO2006036614A2 (en) * | 2004-09-24 | 2006-04-06 | Boehringer Ingelheim Pharmaceuticals, Inc. | A new class of surfactant-like materials comprising vitamin e tpgs and a water soluble polymer |
-
2008
- 2008-01-29 WO PCT/IN2008/000054 patent/WO2008093358A2/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030055102A1 (en) * | 2001-06-27 | 2003-03-20 | Alcon, Inc. | Olopatadine formulations for topical administration |
US6743439B1 (en) * | 2001-06-27 | 2004-06-01 | Alcon, Inc. | Ophthalmic compositions containing copolymers of sulfonated styrene and maleic anhydride |
WO2005020962A1 (en) * | 2003-08-29 | 2005-03-10 | Novagali Pharma Sa | Self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs |
US20050209312A1 (en) * | 2004-03-19 | 2005-09-22 | Bausch & Lomb Incorporated | Carboxylic acid derivatives of doxepin formulations preserved with low-irritation preservative |
WO2006036614A2 (en) * | 2004-09-24 | 2006-04-06 | Boehringer Ingelheim Pharmaceuticals, Inc. | A new class of surfactant-like materials comprising vitamin e tpgs and a water soluble polymer |
Also Published As
Publication number | Publication date |
---|---|
WO2008093358A2 (en) | 2008-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE294159T1 (en) | PREPARATION OF NON-CRYSTALLINE ATORVASTATIN?CALCIUM | |
WO2005117895A8 (en) | Compositions comprising meloxicam | |
AU2002346973A1 (en) | Oral Dosage Form for Propiverine or its Pharmaceutically Acceptable Salts with an Extended Release of the Active Ingredient | |
RS54659B1 (en) | Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cylohexane-1,1'-pyrano[3,4,b]indol]-4-amine | |
DE50212546D1 (en) | ORAL PHARMACEUTICAL FORMS FOR PROPIMERIN OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS WITH EXTENDED ACTIVE INGREDIENT EXTRACTION | |
EP1650192A4 (en) | Quinolone derivative or salt thereof | |
WO2010136474A3 (en) | Substituted aminobutyric derivatives as neprilysin inhibitors | |
WO2001096334A3 (en) | Heteroarylalkanoic acids as integrin receptor antagonists | |
WO2005053612A3 (en) | Micellar systems useful for delivery of lipophilic or hydrophobic compounds | |
MA27107A1 (en) | AEROSOL FORMULATIONS FOR THE PULMONARY ADMINISTRATION OF DRUGS TO PRODUCE A SYSTEMIC EFFECT. | |
WO2007127158A3 (en) | Modification of percutaneous absorption of topically active materials | |
WO2007014124A3 (en) | High drug load formulations and dosage forms | |
WO2009084021A3 (en) | Ophthalmic composition comprising a prostaglandin | |
EP2196206B8 (en) | Remedy for relieving skin troubles comprising morphinan derivative or pharmacologically acceptable acid addition salt thereof as the active ingredient | |
WO2006008173A3 (en) | Pharmaceutical formulations for inhalation | |
NO20024237D0 (en) | Pharmaceutical Formulations | |
WO2001027110A3 (en) | Bicyclic imidazo-3-yl-amine derivatives which are substituted on the sixth ring | |
AU2001278772A1 (en) | Benzoic acid derivatives and drugs containing the same as the active ingredient | |
WO2008093358A3 (en) | Aqueous topical solution containing olopatadine | |
AU2001234107A1 (en) | Benzoic acid derivatives, process for producing the same and drugs containing the same as the active ingredient | |
WO2003092655A3 (en) | Use of active ingredient mixtures with azelaic acids and glycyrrhetic acids as anti-acne agents | |
WO2003039577A1 (en) | Remedies for dry eye and diseases associated with dry eye | |
WO2002011709A3 (en) | Pharmaceutical, effervescent formulation containing ramipril | |
DE60107832D1 (en) | Chromenylmethylpyrimidindiamine als antibakterielle wirkstoffe | |
WO2002004012A8 (en) | Anhydrous pharmaceutical composition of vancomycin for topical use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08720115 Country of ref document: EP Kind code of ref document: A2 |
|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08720115 Country of ref document: EP Kind code of ref document: A2 |